Functional and cognitive outcome in prolonged refractory status epilepticus

Archives of Neurology

Volumn 66, Issue 12, 2009, Pages 1505-1509

  Cooper, Alex D ^a   Britton, Jeffrey W ^a   Rabinstein, Alejandro A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTICONVULSIVE AGENT; BENZODIAZEPINE; CLONAZEPAM; DIAZEPAM; ETIRACETAM; FELBAMATE; FOSPHENYTOIN SODIUM; ISOFLURANE; KETAMINE; LIDOCAINE; LORAZEPAM; MIDAZOLAM; PENTOBARBITAL; PHENOBARBITAL; PHENYTOIN; PROPOFOL; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; EPILEPTIC STATE; FEMALE; FOLLOW UP; FUNCTIONAL STATUS; HOSPITALIZATION; HUMAN; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANKIN SCALE; SEIZURE; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STATUS EPILEPTICUS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 73549094220     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2009.273     Document Type: Article

References (33)

1. DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996; 46(4):1029-1035.
2. Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus: frequency, risk factory, and impact on outcome. Arch Neurol. 2002;59(2):205-210.
3. Holtkamp M, Othman J, Buchheim K, Meierkord H. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry. 2005;76(4):534-539.
4. Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia. 1994;35(1):27-34.
5. Holtkamp M, Othman J, Buchheim K, Masuhr F, Schielke E, Meierkord HA. "Malignant" variant of status epilepticus. Arch Neurol. 2005;62(9):1428-1431.
6. Lowenstein DH. The management of refractory status epilepticus: an update. Epilepsia. 2006;47(suppl 1):35-40.
7. Rossetti AO. Which anesthetic should be used in the treatment of refractory status epilepticus? Epilepsia. 2007;48(suppl 8):52-55.
8. Lowenstein DH, Bleck T, Macdonald R. It's time to revise the definition of status epilepticus. Epilepsia. 1999;40(1):120-122.
9. Commission on Epidemiology and Prognosis, International League Against Epilepsy. Guidelines for epidemiologic studies on epilepsy. Epilepsia. 1993;34(4):592-596.
10. Logroscino G, Hesdorffer DC, Cascino G, Annegers JF, Hauser WA. Short-term mortality after a first episode of status epilepticus. Epilepsia. 1997;38(12): 1344-1349.
11. Drislane FW, Blum AS, Lopez MR, Gautam S, Schomer DL. Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours [published online ahead of print January 21, 2009] Epilepsia. 2009;50(6):1566-1571.
12. Fisher RS, van Emde Boas WE, Blume W, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005;46(4):470-472.
13. Glaser CA, Gilliam S, Schnurr D, et al. In search of encephalitis etiologies: diagnostic challenges in the California encephalitis project, 1998-2000. Clin Infect Dis. 2003;36:731-742.
14. Wilson JT, Hareendran A, Grant M, et al. Improving the assessment of outcomes in stroke: use of a structured interview to assign grades on the modified Rankin scale. Stroke. 2002;33(9):2243-2246.
15. Brandt J, Spencer M, Folstein M. The telephone interview for cognitive status. Neuropsychiatry Neuropsychol Behav Neurol. 1988;1(2):111-117.
16. Adachi N, Kanemoto K, Muramatsu R, et al. Intellectual prognosis of status epilepticus in adult epilepsy patients: analysis with Wechsler adult intelligence scale-revised. Epilepsia. 2005;46(9):1502-1509.
17. Friedman LK, Velísková J, Kaur J, Magrys BW, Liu H. GluR2(B) knockdown accelerates CA3 injury after kainite seizures. J Neuropathol Exp Neurol. 2003;62(7):733-750.
18. Fujikawa DG. Prolonged seizures and cellular injury: understanding the connection [published online ahead of print November 8, 2005]. Epilepsy Behav. 2005; 7(suppl 3):S3-S11.
19. Deshpande LS, Lou JK, Mian A, et al. Time course and mechanism of hippocampal neuronal death in an in vitro model of status epilepticus: role of NMDA receptor activation and NMDA dependent calcium entry. Eur J Pharmacol. 2008; 583(1):73-83.
20. Deshpande LS, Lou JK, Mian A, Blair RE, Sombati S, DeLorenzo RJ. In vitro status epilepticus but not spontaneous recurrent seizures cause cell death in cultured hippocampal neurons. Epilepsy Res. 2007;75(2-3):171-179.
21. Claassen J, Lokin JK, Fitzsimmons BFM, Mendelsohn FA, Mayer SA. Predictors of functional disability and mortality after status epilepticus. Neurology. 2002; 58(1):139-142.
22. Oxbury JM, Whitty CW. Causes and consequences of status epilepticus in adults: a study of 86 cases. Brain. 1971;94(4):733-744.
23. Lowenstein DH, Alldredge BK. Status epilepticus at an urban public hospital in the 1980s. Neurology. 1993;43(3 pt 1):483-488.
24. Aminoff MJ, Simon RP. Status epilepticus: causes, clinical features and consequences in 98 patients. Am J Med. 1980;69(5):657-666.
25. Rossetti AO, Logroscino G, Bromfield EB. Effect of treatment aggressiveness on prognosis. Arch Neurol. 2005;62(11):1698-1702.
26. Logroscino G, Hesdorffer DC, Cascino G, et al. Mortality after a first episode of status epilepticus in the United States and Europe. Epilepsia. 2005;46(suppl 11): 46-48.
27. Koubeissi M, Alshekhlee A. In-hospital mortality of generalized convulsive status epilepticus. Neurology. 2007;69(9):886-893.
28. DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epidemiology of status epilepticus. J Clin Neurophysiol. 1995;12(4):316-325.
29. Claassen J, Hirsch LJ, Mayer SA. Treatment of status epilepticus: a survey of neurologists. J Neurol Sci. 2003;211(1-2):37-41.
30. Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia. 2002;43(2):146-153.
31. Prasad A, Worrall BB, Bertram EH, Bleck TP. Propofol and Midazolam in the treatment of refractory status epilepticus. Epilepsia. 2001;42(3):380-386.
32. Iyer VN, Hoel R, Rabinstein AA. Propofol infusion syndrome in patients with refractory status epilepticus: an 11 year clinical experience [published online August 5, 2009]. Crit Care Med.
33. Dara SI, Tungpalan LA, Manno EM, et al. Prolonged coma from refractory status epilepticus. Neurocrit Care. 2006;4(2):140-142.